KATE NEWMAN: Open Payments
NPI 1942434881 · WESTLAKE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$51,788 in 111 payments from 15 companies in 2025. Trend: 2023 $1,674 · 2024 $18,748 · 2025 $51,788
Speaker / faculty: $39,737Travel & lodging: $9,084Food & beverage: $2,967
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 73 | $49,167 |
| Phathom Pharmaceuticals, Inc. | 6 | $1,838 |
| GENZYME CORPORATION | 5 | $200 |
| ABBVIE INC. | 13 | $192 |
| PFIZER INC. | 2 | $121 |
| Novo Nordisk Inc | 1 | $52 |
| Ipsen Biopharmaceuticals, Inc | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| QOL Medical, LLC | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
Products named: TREMFYA, VOQUEZNA, STELARA, DUPIXENT, RINVOQ, VELSIPITY, LINZESS, IQIRVO.
Industry payments across OH — which companies pay providers there.
